Farid Chekani Selected Research

AP protocol 1

1/2022

Cardiometabolic outcomes among schizophrenia patients using antipsychotics: the impact of high weight gain risk vs low weight gain risk treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Farid Chekani Research Topics

Disease

5	Parkinson Disease (Parkinson's Disease) 10/2020 - 01/2016
2	Schizophrenia (Dementia Praecox) 01/2022 - 01/2022
2	Pneumonia (Pneumonitis) 10/2020 - 10/2019
2	Stroke (Strokes) 04/2020 - 01/2019
2	Ischemic Stroke 04/2020 - 01/2019
2	Dementia (Dementias) 01/2020 - 07/2016
1	Weight Gain 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2016

Drug/Important Bio-Agent (IBA)

4	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 10/2019
2	antiarrhythmic peptide (AAP)IBA 10/2020 - 10/2019
1	chloroamide S-330 (S 330)IBA 01/2022
1	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2019
1	Olanzapine (Zyprexa)FDA Link 10/2019
1	Quetiapine Fumarate (Seroquel)FDA Link 10/2019
1	Biological ProductsIBA 07/2016

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2019
2	Length of Stay 04/2020 - 01/2019
2	Home Nursing (Nursing, Home) 10/2019 - 01/2016
1	AP protocol 1 01/2022
1	Long-Term Care 01/2020
1	Activities of Daily Living (ADL) 01/2016